CITIGROUP INC - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 92 filers reported holding SPERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,000
-90.9%
495
-96.6%
0.00%
Q2 2022$11,000
-21.4%
14,362
+808.4%
0.00%
Q1 2022$14,000
-97.3%
1,581
-95.2%
0.00%
Q4 2021$527,000
+78.0%
32,904
+104.6%
0.00%
Q3 2021$296,000
-46.1%
16,085
-59.1%
0.00%
Q2 2021$549,000
-56.6%
39,330
-54.2%
0.00%
-100.0%
Q1 2021$1,265,000
+1177.8%
85,948
+1584.3%
0.00%
Q4 2020$99,000
+450.0%
5,103
+215.0%
0.00%
Q3 2020$18,000
-55.0%
1,620
-45.6%
0.00%
Q2 2020$40,000
+21.2%
2,976
-26.4%
0.00%
Q1 2020$33,000
+43.5%
4,042
+68.6%
0.00%
Q4 2019$23,000
+64.3%
2,398
+85.9%
0.00%
Q3 2019$14,000
-54.8%
1,290
-50.9%
0.00%
Q2 2019$31,000
+24.0%
2,629
+31.2%
0.00%
Q1 2019$25,000
+78.6%
2,004
-11.3%
0.00%
Q4 2018$14,000
-41.7%
2,260
-3.1%
0.00%
Q3 2018$24,000
+26.3%
2,333
+77.4%
0.00%
Q2 2018$19,000
+72.7%
1,315
+64.0%
0.00%
Q1 2018$11,000
+37.5%
802
+17.8%
0.00%
Q4 2017$8,0006810.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders